B.R.A.I.N. Biotechnology Research and Information Network (BNN) Stock Statistics & Valuation Metrics

B.R.A.I.N. Biotechnology Research and Information Network has a market cap or net worth of €50.90M. The enterprise value is €32.10M.

B.R.A.I.N. Biotechnology Research and Information Network has 21,847,494 shares outstanding. The number of shares has decreased by -2.65% in one year.

B.R.A.I.N. Biotechnology Research and Information Network’s return on equity (ROE) is -0.88 and return on invested capital (ROIC) is -12.35%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, B.R.A.I.N. Biotechnology Research and Information Network had revenue of 54.63M and earned -11.13M in profits. Earnings per share was -0.51.

In the last 12 months, operating cash flow was -6.92M and capital expenditures -1.56M, giving a free cash flow of -8.48M billion.

B.R.A.I.N. Biotechnology Research and Information Network pays an annual dividend of ―, resulting in a dividend yield of ―

B.R.A.I.N. Biotechnology Research and Information Network upcoming earnings date is Aug 28, 2025, Before Open (Confirmed).

B.R.A.I.N. Biotechnology Research and Information Network as a current ratio of 1.83, with Debt / Equity ratio of 76.35%

In the past 12 months, B.R.A.I.N. Biotechnology Research and Information Network has paid 111.00K in taxes.

B.R.A.I.N. Biotechnology Research and Information Network EV to EBITDA ratio is -7.56, with an EV/FCF ratio of -6.01.

B.R.A.I.N. Biotechnology Research and Information Network has €17.82M in cash and marketable securities with €0.00 in debt, giving a net cash position of -€17.82M billion.

Gross margin is 54.88%, with operating margin of -16.20%, and net profit margin of -20.37%.

The average price target for B.R.A.I.N. Biotechnology Research and Information Network is €6.90, which is 11.43% higher than the current price. The consensus rating is Moderate Buy